Gujarat Terce Laboratories (BOM:524314) Marketable Securities: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524314 Gujarat Terce Laboratories Ltd BOM:524314
44 GF Score
Price ₹40.69
! 3 Warning Signs
View Full Analysis

What is Gujarat Terce Laboratories Marketable Securities?

Gujarat Terce Laboratories BOM:524314 +1.73% 44 Marketable Securities is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:524314 with a GF Score™ of 44/100. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Gujarat Terce Laboratories's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Gujarat Terce Laboratories's annual Marketable Securities increased from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹10.1 Mil) and increased from Mar. 2025 (₹10.1 Mil) to Mar. 2026 (₹13.5 Mil).

Gujarat Terce Laboratories  (BOM:524314) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Gujarat Terce Laboratories Marketable Securities Related Terms

Gujarat Terce Laboratories Marketable Securities Historical Data

* Premium members only.

The historical data trend for Gujarat Terce Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Terce Laboratories Marketable Securities Chart

Gujarat Terce Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 10.11 13.48

Gujarat Terce Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 26.24 0.00 13.48 0.00
BOM:524314
44GF Score
Gujarat Terce Laboratories Ltd BOM:524314
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Terce Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0.0 Mil mean?
Gujarat Terce Laboratories (BOM:524314) has a Marketable Securities of ₹0.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Gujarat Terce Laboratories and its competitors.
Is Gujarat Terce Laboratories' Marketable Securities too high?
Gujarat Terce Laboratories' current Marketable Securities is ₹0.0 Mil. Overall, Gujarat Terce Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Terce Laboratories' Marketable Securities compare to ZTS?
Gujarat Terce Laboratories' Marketable Securities of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Gujarat Terce Laboratories and its competitors. Gujarat Terce Laboratories's current Marketable Securities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Terce Laboratories stock overvalued right now?
Gujarat Terce Laboratories (BOM:524314) has a current Marketable Securities of ₹0.0 Mil. The current Marketable Securities is ₹0.0 Mil. Gujarat Terce Laboratories' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Gujarat Terce Laboratories (BOM:524314), the current Marketable Securities is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Terce Laboratories Business Description

Address Near Shivalik High-Street, Unit No. D/801-802 and 1202,The First, Behind Keshavbaug Party Plot, Vastrapur, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an Indian company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, syrup, and injections. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, antifungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash, Aziter, and others.
44GF Score

Get the complete analysis for BOM:524314

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.69
Price